Literature DB >> 8728301

The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men.

J Filipovský1, P Ducimetiére, E Eschwége, J L Richard, G Rosselin, J R Claude.   

Abstract

OBJECTIVE: To investigate the relationships of blood pressure with carbohydrate metabolism, sympathetic activity and cortisol at different levels of body mass index in middle-aged men.
METHODS: Cross-sectional data concerning men studied in the Paris Prospective Study I were analysed. The cohort included 6424 subjects aged 40-53 years at entry, who were not being treated for hypertension or diabetes and had no overt heart disease. The parameters analysed were glucose, insulin and free fatty acids levels, all assessed during fasting by the subject and 2 h after a 75 g glucose load, resting heart rate and morning plasma cortisol levels.
RESULTS: Subjects with systolic blood pressure > or = 160 mmHg had significantly higher glucose concentrations at any body mass index level whereas the difference in insulin levels between the subjects with and without high systolic blood pressure increased with body mass index. Heart rate, free fatty acids level and cortisol level were significantly higher in men with high systolic blood pressure. However, these parameters showed significant decreasing trends with body mass index. In normotensives, no such trends were observed. When analysing data according to diastolic blood pressure, the limit being 95 mmHg, similar results were obtained for glucose and insulin levels, but no trend in heart rate, free fatty acids level and cortisol level with the body mass index level was statistically significant.
CONCLUSIONS: Mean glucose concentrations are higher in hypertensive men at all body mass index levels, whereas relative hyperinsulinaemia is present only in the more corpulent hypertensives. Heart rate, free fatty acids level and morning plasma cortisol level are elevated in hypertensive subjects at any body mass index level, but particularly in the lean ones with high systolic blood pressure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8728301     DOI: 10.1097/00004872-199602000-00012

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  28 in total

1.  Associations between positive and negative affect and 12-month physical disorders in a national sample.

Authors:  Eric B Weiser
Journal:  J Clin Psychol Med Settings       Date:  2012-06

2.  Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.

Authors:  Anja Miesel; Helge Müller-Fielitz; Olaf Jöhren; Florian M Vogt; Walter Raasch
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  An epidermal patch for the simultaneous monitoring of haemodynamic and metabolic biomarkers.

Authors:  Juliane R Sempionatto; Muyang Lin; Lu Yin; Ernesto De la Paz; Kexin Pei; Thitaporn Sonsa-Ard; Andre N de Loyola Silva; Ahmed A Khorshed; Fangyu Zhang; Nicholas Tostado; Sheng Xu; Joseph Wang
Journal:  Nat Biomed Eng       Date:  2021-02-15       Impact factor: 25.671

4.  Effect of restorative yoga vs. stretching on diurnal cortisol dynamics and psychosocial outcomes in individuals with the metabolic syndrome: the PRYSMS randomized controlled trial.

Authors:  Sarah M Corey; Elissa Epel; Michael Schembri; Sarah B Pawlowsky; Roger J Cole; Maria Rosario G Araneta; Elizabeth Barrett-Connor; Alka M Kanaya
Journal:  Psychoneuroendocrinology       Date:  2014-07-21       Impact factor: 4.905

5.  Altered response to neuroendocrine challenge linked to indices of the metabolic syndrome in healthy adults.

Authors:  A R Tyrka; O C Walters; L H Price; G M Anderson; L L Carpenter
Journal:  Horm Metab Res       Date:  2012-04-27       Impact factor: 2.936

6.  Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

Authors:  P C Souverein; A Berard; T P Van Staa; C Cooper; A C G Egberts; H G M Leufkens; B R Walker
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 7.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

8.  Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study.

Authors:  Rebecca M Reynolds; Javier Labad; Mark W J Strachan; Anke Braun; F Gerry R Fowkes; Amanda J Lee; Brian M Frier; Jonathan R Seckl; Brian R Walker; Jackie F Price
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

9.  Variation in the SERPINA6/SERPINA1 locus alters morning plasma cortisol, hepatic corticosteroid binding globulin expression, gene expression in peripheral tissues, and risk of cardiovascular disease.

Authors:  Andrew A Crawford; Sean Bankier; Elisabeth Altmaier; Catriona L K Barnes; David W Clark; Raili Ermel; Nele Friedrich; Pim van der Harst; Peter K Joshi; Ville Karhunen; Jari Lahti; Anubha Mahajan; Massimo Mangino; Maria Nethander; Alexander Neumann; Maik Pietzner; Katyayani Sukhavasi; Carol A Wang; Stephan J L Bakker; Johan L M Bjorkegren; Harry Campbell; Johan Eriksson; Christian Gieger; Caroline Hayward; Marjo-Riitta Jarvelin; Stela McLachlan; Andrew P Morris; Claes Ohlsson; Craig E Pennell; Jackie Price; Igor Rudan; Arno Ruusalepp; Tim Spector; Henning Tiemeier; Henry Völzke; James F Wilson; Tom Michoel; Nicolas J Timpson; George Davey Smith; Brian R Walker
Journal:  J Hum Genet       Date:  2021-01-20       Impact factor: 3.172

10.  Cortisol and the metabolic syndrome in South Asians.

Authors:  Alexandra M V Ward; Caroline H D Fall; Claudia E Stein; K Kumaran; S R Veena; Peter J Wood; Holly E Syddall; David I W Phillips
Journal:  Clin Endocrinol (Oxf)       Date:  2003-04       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.